WEEKLY e-ALERT [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
  • Industry News
  • China Approves 62 Novel Drugs in H1 2025, Led by Small Molecules and Antibodies(7/8/2025) (Premium)
  • China's Biotech Financing Hits 10-Year Low in First Half of 2025(7/8/2025) (Premium)
  • Sagent and Qilu Announce Partnership for Critical Injectables in U.S.(7/8/2025) (Premium)
  • CStone and Istituto Gentili Forge Partnership for Sugemalimab in Western Europe and the UK(7/8/2025) (Premium)
  • Fosun USA and MAP International Partner to Expand Medicine Access(7/8/2025) (Premium)
  • XellSmart Completes New Financing, Secures FDA Clearance for iPSC-Derived CNS Cell Therapies(7/8/2025) (Premium)
  • Novo Nordisk Commits CNY 800M to Expand Quality Lab at Tianjin Manufacturing Hub(7/8/2025) (Premium)
  • Adagene and ConjugateBio Launch a Strategic Partnership to Advance Bispecific ADCs(7/9/2025) (Premium)
  • NKCellTech Secures Nearly CNY100M in Series A+++ Financing(7/9/2025) (Premium)
  • China's Biopharma Licensing Deals Surge in H1 2025, Fueled by Cross-Border Out-Licensing to U.S.(7/10/2025) (Premium)
  • Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform(7/10/2025) (Premium)
  • China Approves Three New Drugs for Cancer, ED and Pediatric Sleep Disorders(7/10/2025) (Premium)
  • Haleon Secures Full Ownership of Tianjin Sino‑American JV(7/11/2025) (Premium)
  • TandemAI and Perpetual Medicine Announce Strategic Merger(7/11/2025) (Premium)
  • Biocytogen Strengthens Ties with BeOne Thru Expanded Antibody Licensing Deal(7/11/2025) (Premium)
  • Vice Premier Urges Stronger Focus on Basic Pharmaceutical Research and Innovation(7/11/2025) (Premium)
  • Flamma Opens New cGMP Plant in Dalian(7/12/2025) (Premium)
  • China's First 9-Valent HPV Vaccine Launches at 60% Discount, Undercutting Merck's Gardasil 9(7/12/2025) (Premium)
  • People in the News
  • ​​​​​​​Recent Official and Executive Moves(7/12/2025) (Premium)
  • Home | Contact Us | Subscribe
  • © Wicon International Group